Start here if you're new
what it is
It cleans up radioactive and mixed waste for government, hospital, lab, and commercial customers.
how it gets paid
Last year Perma-Fix Environ made $59M in revenue. Treatment Services was the main engine at $19.0M, or 32% of sales.
what just happened
Revenue hit $46M, while EPS was -$0.44.
At a glance
B balance sheet — gets the job done, barely
25/100 earnings predictability — expect surprises
2.7% return on capital — nothing to write home about
-$1.30 fy2024 eps est
$59M fy2024 rev est
xvary composite: 47/100 — below average
What they do
It cleans up radioactive and mixed waste for government, hospital, lab, and commercial customers.
Perma-Fix runs 4 nuclear waste treatment facilities with 293 employees. That is a tiny company handling a job most trash firms cannot touch. Decontamination and decommissioning means cleaning old nuclear sites, and your DOE or DOD customer has few places to go.
How they make money
$59M
annual revenue
Treatment Services
$19.0M
Nuclear Services
$15.0M
Waste Management
$11.0M
Decontamination & Decommissioning
$8.0M
Environmental Restoration
$6.0M
The products that matter
treats radioactive and hazardous waste
Treatment Services
core revenue driver
This is the operating core of a business expected to generate $59M in revenue, and the whole company only kept a 10.4% gross margin last year.
10.4% gross margin
manages nuclear cleanup work
Nuclear Services
contract-driven demand
This work matters because contract timing can swing results in a company expected to lose $1.30 per share for FY2024.
lumpy revenue
Key numbers
$59M
annual revenue
and EDGAR both point to $59M. On a company this small, one contract can matter.
26.5%
operating margin
That means 26.5 cents lost on every sales dollar. On $59M, that is about $15.6M of operating loss.
$3M
long-term debt
The company owes $3M long term, or 1% of capital. The balance sheet is not the problem.
10.4%
gross margin
The business keeps 10.4 cents before overhead. That is thin when projects swing.
Financial health
B
strength
- balance sheet grade B — adequate — nothing special
- risk rank 3 — safer than 50% of stocks
- price stability 15 / 100
- long-term debt $3M (1% of capital)
B — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for PESI right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue hit $46M, while EPS was -$0.44.
Revenue rose 163% vs. prior year, but gross margin was only 10.4%. That left little room after project costs.
$46M
revenue
$0.44
eps
10.4%
gross margin
the number that mattered
10.4% gross margin means 89.6 cents of each sales dollar went to cost before overhead.
source: company earnings report
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is government contract timing in nuclear waste treatment.
high
contract timing and customer concentration
A business expected to do just $59M in revenue does not have much room for a major award to slip by a quarter or two. When work is episodic, your income statement becomes episodic too.
Revenue volatility is the main issue, not a side issue.
high
thin margin structure
Gross margin was 10.4% last year. That means small execution mistakes, pricing pressure, or underutilized facilities can erase what little cushion the business has.
Low margin businesses do not get many free mistakes.
med
expected losses can persist longer than the stock market allows for
FY2024 EPS is still estimated at -$1.30. If the company stays unprofitable after a 79% stock run, valuation support gets thin very quickly.
Momentum is helpful until it meets another unprofitable quarter.
med
share price volatility
Price stability is 15/100. In plain English: this stock moves around a lot, and small caps with thin fundamentals rarely move politely.
You can be right on the business and still get a rough ride on the stock.
A company expected to produce $59M in revenue with a 10.4% gross margin and negative EPS has very little buffer if a contract slips or costs run high.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
march 19, 2026 earnings report
This is the next hard checkpoint. You want more than narrative — you want revenue, margin, and contract commentary that actually improves the math.
metric
gross margin above 10.4%
That is the number to watch because it tells you whether this niche service business is gaining any pricing power or operating leverage at all.
trend
whether revenue stops shrinking
Revenue fell 34.1% from last year to an estimated $59M. The first step in any real recovery is making that number go the other direction.
risk
contract timing language from management
Because the business is small, a delayed award can distort the whole quarter. Listen for timing shifts, not just optimistic backlog talk.
Analyst rankings
earnings predictability
25 / 100
in human-speak, analysts do not see a clean earnings pattern here — expect swings.
risk rank
3
Safer than roughly half the market. Not a disaster, not a safe haven.
price stability
15 / 100
The business may be niche. The stock still behaves like a volatile small cap.
source: institutional data
Institutional activity
institutional ownership data for PESI is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$16
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive